Primary hypertriglyceridemia in children and adolescents

Journal of Clinical Lipidology

Volumn 9, Issue 5, 2015, Pages S20-S28

  Shah, Amy S ^a   Wilson, Don P ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b Cook Children's Medical Center ^*  (United States)

Author keywords

Adolescents; Children; Familial; Hypertriglyceridemia; Inherited; Pancreatitis

Indexed keywords

ANGPTL INHIBITOR; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; APOB ANTISENSE; APOC III ANTISENSE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID SEQUESTRANT; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; DIACYLGLYCEROL ACYLTRANSFERASE 1 INHIBITOR; DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR; ESTROGEN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; MTP INHIBITOR; NEUROLEPTIC AGENT; NICOTINIC ACID; OMEGA 3 ACID ETHYL ESTER; OMEGA 3 FATTY ACID; PCSK9 INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; RAPAMYCIN; ROSIGLITAZONE; STEROID; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; FAMILIAL HYPERLIPEMIA; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIFESTYLE; OBESITY; PANCREATITIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; ADOLESCENT; CHILD; COMPLICATION; ENZYMOLOGY; MASS SCREENING; PATHOLOGY; RISK FACTOR;

ADOLESCENT; CHILD; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; HYPERLIPOPROTEINEMIA TYPE III; HYPERTRIGLYCERIDEMIA; MASS SCREENING; PANCREATITIS; RISK FACTORS;

EID: 84940953456     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.04.004     Document Type: Review

References (67)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
2. J.B. Christian, M.X. Juneja, A.M. Meadowcroft, S. Borden, and K.A. Lowe Prevalence, characteristics, and risk factors of elevated triglyceride levels in US children Clin Pediatr (Phila) 50 2011 1103 1109
3. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents Pediatrics 89 1992 495 501
4. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report Pediatrics 128 Suppl 5 2011 S213 S256
5. L. Berglund, J.D. Brunzell, A.C. Goldberg, and et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 97 2012 2969 2989
6. S. Santamarina-Fojo The familial chylomicronemia syndrome Endocrinol Metab Clin North Am 27 1998 551 567 viii
7. M.R. Hayden, and Y. Ma Molecular genetics of human lipoprotein lipase deficiency Mol Cell Biochem 113 1992 171 176
8. B. Gilbert, M. Rouis, S. Griglio, L. de Lumley, and P. Laplaud Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6 Ann Genet 44 2001 25 32
9. A.R. Rahalkar, F. Giffen, B. Har, and et al. Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review Can J Physiol Pharmacol 87 2009 151 160
10. M.A. Kawashiri, T. Higashikata, M. Mizuno, and et al. Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis J Clin Endocrinol Metab 90 2005 6541 6544
11. S.S. Fojo, and H.B. Brewer Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II J Intern Med 231 1992 669 677
12. R.H. Eckel Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases N Engl J Med 320 1989 1060 1068
13. C. Priore Oliva, L. Pisciotta, G. Li Volti, and et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia Arterioscler Thromb Vasc Biol 25 2005 411 417
14. C.T. Johansen, and R.A. Hegele Genetic bases of hypertriglyceridemic phenotypes Curr Opin Lipidol 22 2011 247 253
15. J.D. Brunzell, N.E. Miller, P. Alaupovic, and et al. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity J Lipid Res 24 1983 12 19
16. D.S. Fredrickson, and R.S. Lees A system for phenotyping hyperlipoproteinemia Circulation 31 1965 321 327
17. K.W. Holmes, and P.O. Kwiterovich Jr. Treatment of dyslipidemia in children and adolescents Curr Cardiol Rep 7 2005 445 456
18. J.A. Cortner, P.M. Coates, and P.R. Gallagher Prevalence and expression of familial combined hyperlipidemia in childhood J Pediatr 116 1990 514 519
19. B.E. Aouizerat, H. Allayee, R.M. Cantor, and et al. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11 Am J Hum Genet 65 1999 397 412
20. P. Pajukanta, I. Nuotio, J.D. Terwilliger, and et al. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23 Nat Genet 18 1998 369 373
21. P. Pauciullo, M. Gentile, G. Marotta, and et al. Small dense low-density lipoprotein in familial combined hyperlipidemia: independent of metabolic syndrome and related to history of cardiovascular events Atherosclerosis 203 2009 320 324
22. A.F. Ayyobi, S.H. McGladdery, M.J. McNeely, M.A. Austin, A.G. Motulsky, and J.D. Brunzell Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia Arterioscler Thromb Vasc Biol 23 2003 1289 1294
23. R. Shamir, A.M. Tershakovec, P.R. Gallagher, C.A. Liacouras, L.L. Hayman, and J.A. Cortner The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood Atherosclerosis 121 1996 85 91
24. P. Durrington Dyslipidaemia Lancet 362 2003 717 731
25. J.L. Goldstein, H.G. Schrott, W.R. Hazzard, E.L. Bierman, and A.G. Motulsky Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia J Clin Invest 52 1973 1544 1568
26. S.B. Clauss, and P.O. Kwiterovich Jr. Genetic disorders of lipoprotein transport in children Prog Pediatr Cardiol 17 2003 123 133
27. A. Bouaziz Abed, I. Maaloul, R. Mustapha, M. Chiha, and K. Aissa Primary hypertriglyceridemia type IV: early presentation of a severe case Tunis Med 91 2013 683
28. C. Manlhiot, P. Larsson, R.C. Gurofsky, and et al. Spectrum and management of hypertriglyceridemia among children in clinical practice Pediatrics 123 2009 458 465
29. R. Arya, J. Blangero, K. Williams, and et al. Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans Diabetes 51 2002 841 847
30. R. Duggirala, J. Blangero, L. Almasy, and et al. A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans Am J Hum Genet 66 2000 1237 1245
31. J.D. Brunzell Clinical practice. Hypertriglyceridemia N Engl J Med 357 2007 1009 1017
32. M.S. Tullu, A.V. Advirkar, R.G. Ghildiyal, and S. Tambe Familial hypertriglyceridemia Indian J Pediatr 75 2008 1257 1258
33. D.J. Blom, P. Byrnes, S. Jones, and A.D. Marais Dysbetalipoproteinaemia-clinical and pathophysiological features S Afr Med J 92 2002 892 897
34. A. Ziemer, and H.D. Goring Severe type III hyperlipoproteinemia with unusual lipoprotein phenotype in an adolescent patient Hautarzt 44 1993 538 544
35. M. Fung, J. Hill, D. Cook, and J. Frohlich Case series of type III hyperlipoproteinemia in children BMJ Case Rep 2011 2011 1 7
36. A.D. Marais, G.A. Solomon, and D.J. Blom Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E Crit Rev Clin Lab Sci 51 2014 46 62
37. R.W. Mahley Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
38. R.W. Mahley, T.L. Innerarity, S.C. Rall Jr., and K.H. Weisgraber Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia Ann N Y Acad Sci 454 1985 209 221
39. S.B. Hulley, R.H. Rosenman, R.D. Bawol, and R.J. Brand Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease N Engl J Med 302 1980 1383 1389
40. M.H. Criqui, G. Heiss, R. Cohn, and et al. Plasma triglyceride level and mortality from coronary heart disease N Engl J Med 328 1993 1220 1225
41. A. Fontbonne, E. Eschwege, F. Cambien, and et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study Diabetologia 32 1989 300 304
42. M.A. Austin, B. McKnight, K.L. Edwards, and et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study Circulation 101 2000 2777 2782
43. H. Kim, S.M. Marcovina, K.L. Edwards, and et al. Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemia Clin Genet 60 2001 188 197
44. M.H. Murad, A. Hazem, F. Coto-Yglesias, and et al. The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis BMC Endocr Disord 12 2012 2
45. M. Miller, N.J. Stone, C. Ballantyne, and et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association Circulation 123 2011 2292 2333
46. M.R. Fortson, S.N. Freedman, and P.D. Webster 3rd Clinical assessment of hyperlipidemic pancreatitis Am J Gastroenterol 90 1995 2134 2139
47. V.G. Athyros, O.I. Giouleme, N.L. Nikolaidis, and et al. Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis J Clin Gastroenterol 34 2002 472 475
48. J. Scherer, V.P. Singh, C.S. Pitchumoni, and D. Yadav Issues in hypertriglyceridemic pancreatitis: an update J Clin Gastroenterol 48 2014 195 203
49. N.R. Balanescu, L. Topor, A. Ulici, and F.B. Djendov Acute pancreatitis secondary to hyperlipidemia in an 11-year-old girl: a case report and review of literature J Med Life 6 2013 2 6
50. J.E. Dominguez-Munoz, P. Malfertheiner, H.H. Ditschuneit, and et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease Int J Pancreatol 10 1991 261 267
51. C.A. Sanchez-Ramirez, A. Larrosa-Haro, S. Flores-Martinez, J. Sanchez-Corona, A. Villa-Gomez, and R. Macias-Rosales Acute and recurrent pancreatitis in children: etiological factors Acta Paediatr 96 2007 534 537
52. S.I. Gan, A.L. Edwards, C.J. Symonds, and P.L. Beck Hypertriglyceridemia-induced pancreatitis: a case-based review World J Gastroenterol 12 2006 7197 7202
53. G. Yuan, K.Z. Al-Shali, and R.A. Hegele Hypertriglyceridemia: its etiology, effects and treatment CMAJ 176 2007 1113 1120
54. R.K. Johnson, L.J. Appel, M. Brands, and et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association Circulation 120 2009 1011 1020
55. R.P. Mensink, P.L. Zock, A.D. Kester, and M.B. Katan Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials Am J Clin Nutr 77 2003 1146 1155
56. T.M. Wolever, D.J. Jenkins, A.L. Jenkins, and R.G. Josse The glycemic index: methodology and clinical implications Am J Clin Nutr 54 1991 846 854
57. T.E. Graham Exercise, postprandial triacylglyceridemia, and cardiovascular disease risk Can J Appl Physiol 29 2004 781 799
58. M. Rouis, K.A. Dugi, L. Previato, and et al. Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronemia syndrome Arterioscler Thromb Vasc Biol 17 1997 1400 1406
59. R.S. Araujo, P. Ramos Ade, and A. Borges Mde Bezafibrate in an infant with congenital generalized lipodystrophy and severe hypertriglyceridemia Arq Bras Endocrinol Metabol 57 2013 653 658
60. D. Ellis, T.J. Orchard, S. Lombardozzi, and et al. Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity J Am Soc Nephrol 6 1995 1170 1177
61. N. Vivatrat, B.A. Barshop, and K.L. Jones Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia Am J Med Genet A 149a 2009 2557 2559
62. M.H. Frick, O. Elo, K. Haapa, and et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease N Engl J Med 317 1987 1237 1245
63. A. Keech, R.J. Simes, P. Barter, and et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial Lancet 366 2005 1849 1861
64. S.M. Grundy, and G.L. Vega Fibric acids: effects on lipids and lipoprotein metabolism Am J Med 83 1987 9 20
65. K. Musa-Veloso, M.A. Binns, A.C. Kocenas, and et al. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides Nutr Rev 68 2010 155 167
66. N. Ewald, and H.U. Kloer Severe hypertriglyceridemia: an indication for apheresis? Atheroscler Suppl 10 2009 49 52
67. C. Stefanutti, S. Di Giacomo, A. Vivenzio, and et al. Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study Artif Organs 33 2009 1096 1102